Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1981 Mar;72(3):477–482. doi: 10.1111/j.1476-5381.1981.tb10999.x

Different hypothalamic receptors mediate 5-hydroxytryptamine- and tryptamine-induced core temperature changes in the rat.

B Cox, T F Lee, D Martin
PMCID: PMC2071590  PMID: 7260487

Abstract

1 Unilateral intrahypothalamic injection of 5-hydroxytryptamine (5-HT) caused a dose-related fall in core temperature in rats, whereas injection of tryptamine into the same site caused a dose-related rise in core temperature. 2 The core temperature changes induced by 5-HT or tryptamine were inhibited by intrahypothalamic pretreatment with indoleamine receptor antagonists in a dose-related manner. 3 Other neurotransmitter antagonists, haloperidol, atropine, phentolamine and (-)-propranolol, had no significant effect on core temperature changes induced by 5-HT or tryptamine. 4 A differential antagonism was observed for the indoleamine receptor antagonists against 5-HT and tryptamine-induced core temperature changes. Methergoline and triflupromazine were more selective against tryptamine-induced hyperthermia, while cyproheptadine was more selective against 5-HT-induced hypothermia. 5 Intrahypothalamic pretreatment with 5,-7-dihydroxytryptamine (5,7-DHT) 42 nmol in 2 microliter inhibited tryptamine-induced hyperthermia, but was without effect on 5-HT-induced hypothermia. 6 These results suggest the possible existence of two different receptor populations within the preoptic anterior hypothalamus in rats; one specific for 5-HT and the other for tryptamine.

Full text

PDF
482

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Björklund A., Baumgarten H. G., Rensch A. 5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine. J Neurochem. 1975 Apr;24(4):833–835. [PubMed] [Google Scholar]
  2. Clineschmidt B. V., Lotti V. J. Indoleamine antagonists: relative potencies as inhibitors of tryptamine- and 5-hydroxytryptophan-evoked responses. Br J Pharmacol. 1974 Feb;50(2):311–313. doi: 10.1111/j.1476-5381.1974.tb08577.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cox B., Kerwin R. W., Lee T. F., Pycock C. J. A dopamine-5-hydroxytryptamine link in the hypothalamic pathways which mediate heat loss in the rat. J Physiol. 1980 Jun;303:9–21. doi: 10.1113/jphysiol.1980.sp013266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cox B., Lee T. F. Possible involvement of 5-hydroxytryptamine in dopamine-receptor-mediated hypothermia in the rat. J Pharm Pharmacol. 1979 May;31(5):352–354. doi: 10.1111/j.2042-7158.1979.tb13521.x. [DOI] [PubMed] [Google Scholar]
  5. Dooley D. J., Quock R. M. Tryptamine and 5-hydroxytryptamine-induced hypothermia in mice. J Pharm Pharmacol. 1976 Oct;28(10):775–776. doi: 10.1111/j.2042-7158.1976.tb04048.x. [DOI] [PubMed] [Google Scholar]
  6. Frankhuijzen A. L., Bonta I. L. Receptors involved in the action of 5-HT and tryptamine on the isolated rat stomach fundus preparation. Eur J Pharmacol. 1974 May;26(2):220–230. doi: 10.1016/0014-2999(74)90231-3. [DOI] [PubMed] [Google Scholar]
  7. Knott P. J., Marsden C. A., Curzon G. Comparative studies of brain 5-hydroxytryptamine and tryptamine. Adv Biochem Psychopharmacol. 1974;11(0):109–114. [PubMed] [Google Scholar]
  8. Lorden J. F., Oltmans G. A., Dawson R., Jr, Callahan M. Evaluation of the non-specific effects of catecholamine and serotonin neurotoxins by injection into the medial forebrain bundle of the rat. Pharmacol Biochem Behav. 1979 Jan;10(1):79–86. doi: 10.1016/0091-3057(79)90172-2. [DOI] [PubMed] [Google Scholar]
  9. Quock R. M., Weick B. G. Tryptamine-induced drug effects insensitive to serotoninergic antagonists: evidence of specific tryptaminergic receptor stimulation? J Pharm Pharmacol. 1978 May;30(5):280–283. doi: 10.1111/j.2042-7158.1978.tb13229.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES